CRISPR THERAPEUTICS Trademark

Trademark Overview

On Wednesday, April 11, 2018, a trademark application was filed for CRISPR THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CRISPR THERAPEUTICS trademark a serial number of 87872064. The federal status of this trademark filing is REGISTERED as of Tuesday, May 12, 2020. This trademark is owned by CRISPR Therapeutics AG. The CRISPR THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical products and preparations, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders
crispr therapeutics

General Information

Serial Number87872064
Word MarkCRISPR THERAPEUTICS
Filing DateWednesday, April 11, 2018
Status700 - REGISTERED
Status DateTuesday, May 12, 2020
Registration Number6055218
Registration DateTuesday, May 12, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of an incomplete square with a break in the lower right of the square. At the bottom of the square below the break appears a shaded rectangle. In the lower middle of the square appears the stylized word "CRISPR" with the second "R" connected to the square. In the shaded rectangle appears the stylized word "THERAPEUTICS".
Goods and ServicesCells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical products and preparations, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 19, 2018
Primary Code005
First Use Anywhere DateMonday, July 22, 2019
First Use In Commerce DateMonday, July 22, 2019

Trademark Owner History

Party NameCRISPR Therapeutics AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressZUG V8 6300
CH
Party NameCRISPR Therapeutics AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4051
CH

Trademark Events

Event DateEvent Description
Wednesday, April 28, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 28, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, August 7, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 7, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, August 7, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 7, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 5, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 5, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 5, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, August 5, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 5, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 5, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 12, 2020REGISTERED-SUPPLEMENTAL REGISTER
Thursday, April 9, 2020LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, April 2, 2020NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Wednesday, April 1, 2020APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Wednesday, April 1, 2020USE AMENDMENT ACCEPTED
Friday, March 27, 2020AMENDMENT TO USE PROCESSING COMPLETE
Friday, March 27, 2020USE AMENDMENT FILED
Friday, March 27, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 27, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 25, 2020TEAS AMENDMENT OF USE RECEIVED
Wednesday, March 25, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 27, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 27, 2019NON-FINAL ACTION E-MAILED
Friday, September 27, 2019NON-FINAL ACTION WRITTEN
Tuesday, September 17, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 17, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 13, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 26, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 26, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 13, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 13, 2019NON-FINAL ACTION E-MAILED
Wednesday, March 13, 2019NON-FINAL ACTION WRITTEN
Thursday, February 21, 2019DIVISIONAL PROCESSING COMPLETE
Thursday, February 7, 2019DIVISIONAL REQUEST RECEIVED
Thursday, February 21, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 13, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 12, 2019ASSIGNED TO LIE
Thursday, February 7, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 7, 2019TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, August 7, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 7, 2018NON-FINAL ACTION E-MAILED
Tuesday, August 7, 2018NON-FINAL ACTION WRITTEN
Tuesday, July 31, 2018ASSIGNED TO EXAMINER
Friday, April 20, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, April 19, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

therapeutics crispr disease disorders treatment pharmaceutical autoimmune preparations inflammatory transplant rejections biopharmaceutical